InspireMD

Stent System Technology for Preventing Embolization

Health Tech & Life Sciences
Active
Public Tel Aviv-Yafo Founded 2005
Total raised
$229.5M
Last: PIPE 2025-08
Stage
Public
Founded
2005
Headcount
112
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery.

InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for sustained embolic protection, neurovascular protection and stroke prevention. InspireMD is focused on changing the carotid/neurovascular market through expanding its portfolio of solutions along with pursuing applications of its MicroNet technology in other indications such as peripheral artery procedures.

Funding history · 7 rounds · $229.5M total

2025-08
PIPE $58.0M
2023-05
PIPE $113.6M
2014-11
PIPE $8.1M
2013-10
PIPE $10.0M
2013-01
PIPE $3.1M
2012-11
PIPE $1.8M
2010-08
Convertible Debt $1.6M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

vascularhospitalsmedical-devicessurgerycardiologypreventionstentdoctorshealthcare-providersclinicsneurovascularstroketreatments